Protective Effects of Oroxylin A on Retinal Ganglion Cells in Experimental Model of Anterior Ischemic Optic Neuropathy
Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of acute vision loss in older people, and there is no effective therapy. The effect of the systemic or local application of steroids for NAION patients remains controversial. Oroxylin A (OA) (5,7-dihydroxy-6-methoxyflav...
Main Authors: | Jia-Ying Chien, Shu-Fang Lin, Yu-Yau Chou, Chi-Ying F. Huang, Shun-Ping Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/6/902 |
Similar Items
-
Protective effects of compound M01 on retinal ganglion cells in experimental anterior ischemic optic neuropathy by inhibiting TXNIP/NLRP3 inflammasome pathway
by: Jia-Ying Chien, et al.
Published: (2023-12-01) -
The Protective Effects of n-Butylidenephthalide on Retinal Ganglion Cells during Ischemic Injury
by: Yu-Yau Chou, et al.
Published: (2022-02-01) -
The Effects of Two Nrf2 Activators, Bardoxolone Methyl and Omaveloxolone, on Retinal Ganglion Cell Survival during Ischemic Optic Neuropathy
by: Jia-Ying Chien, et al.
Published: (2021-09-01) -
Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies
by: Vittorio Porciatti, et al.
Published: (2021-06-01) -
Oroxylin A shows limited antiviral activity towards dengue virus
by: Thippayawan Ratanakomol, et al.
Published: (2022-05-01)